Related Experiment Videos
Abnormal fat metabolism in chronic renal failure
Acta Medica Academiae Scientiarum Hungaricae
|January 1, 1978
Summary
Patients undergoing hemodialysis for chronic kidney disease often exhibit abnormal lipid profiles, including high triglycerides and low cholesterol. Impaired lipoprotein lipase activity further complicates their lipid metabolism.
Area of Science:
- Nephrology
- Clinical Biochemistry
- Lipid Metabolism
Background:
- Chronic renal failure (CRF) often leads to complex metabolic disturbances.
- Patients on hemodialysis (HD) present unique challenges in managing comorbidities, including dyslipidemia.
Purpose of the Study:
- To investigate serum lipid profiles and lipoprotein lipase activity in patients with chronic renal failure undergoing hemodialysis.
- To characterize the specific lipid abnormalities and their relationship with enzyme function in this patient group.
Main Methods:
- Serum triglyceride and cholesterol levels were measured.
- Lipoprotein fractions (VLDL, LDL, HDL) were analyzed for cholesterol and triglyceride content.
- Postheparin lipoprotein lipase activity (PHLA) was assessed at 10 and 20 minutes post-heparin administration.
Main Results:
- Patients exhibited hypertriglyceridemia and hypocholesterolemia.
- Increased triglyceride concentrations were observed in very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) + high-density lipoprotein (HDL) fractions.
- A significant decrease in high-density lipoprotein (HDL) cholesterol was noted.
- Postheparin lipoprotein lipase activity (PHLA) showed normal levels at 10 minutes but decreased significantly by 20 minutes after heparin administration.
Conclusions:
- Hemodialysis patients with chronic renal failure display significant dyslipidemia characterized by elevated triglycerides and reduced HDL cholesterol.
- Impaired postheparin lipoprotein lipase activity suggests a potential mechanism contributing to the observed lipid abnormalities in CRF patients.